[Efficacy and safety of venetoclax and azacitidine in the treatment of refractory and relapsed acute myeloid leukemia].
作者信息
Zong L H, Wu X X, Zhang J, Li M Y, Song B Q, Kong J Y, Kong X, Hu X H, Bao X B, Qiu H Y, Wu D P
机构信息
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou 215006.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Oct 14;42(10):861-864. doi: 10.3760/cma.j.issn.0253-2727.2021.10.012.
Abstract
摘要
Zotero 插件